The largest community of pharma leaders

OncoCell MDx Appoints Marc Stapley to its Board of Directors

ROYAL OAK, Mich.–(BUSINESS WIRE)–#OncoCellMDx–OncoCell MDx, an immunogenomics platform company developing novel, noninvasive molecular diagnostic assays for cancer and other disease, today announced that Marc Stapley has joined the company’s Board of Directors. “I am excited to have Marc Stapley join the OncoCell Board of Directors. Marc brings a wealth of relevant experience as an executive and a board member to our team, including a track record of growing and transforming companies in the genomics and…

Recent Articles